Table 2.

Comparison of IHC Scores between SND1 and AMACR Stratified by Final Diagnosis, PSA, Gleason score, and Pathological Stage for 62 Radical Prostatectomy Specimens

IHC score	SND1						AMACR
	0	1	2	3	Mean	P*	0	1	2	3	Mean	P*
No. cancer total	2	14	40	6	1.8	<0.0001	0	6	25	31	2.4	<0.0001
No. PSA (ng/ml)						0.012						0.85
<10	0	9	10	1	1.6		0	2	9	9	2.4
10<20	2	5	20	1	1.7		0	2	9	9	2.4
>20	0	0	9	3	2.3		0	0	6	6	2.5
No. Gleason score						0.025						0.65
2<6	1	7	9	0	1.5		0	2	8	7	2.3
7	1	4	23	2	1.9		0	4	10	16	2.4
8<10	0	3	8	4	2.1		0	0	7	8	2.5
No. pathological stage						0.95						0.60
pT2	1	8	25	4	1.8		0	4	16	18	2.4
pT3	1	5	16	2	1.8		0	2	9	13	2.5
No. HGPIN	7	31	4	0	0.93		4	33	5	0	1.0
No. hyperplasia	37	14	0	0	0.24		27	24	0	0	0.47
No. normal gland	47	15	0	0	0.27		34	28	0	0	0.45

^*P value for differences mean score among groups of cancer, HGPIN, hyperplasia and normal gland, and each group of PSA. Gleason scores were assessed using the Kruskal-Wallis test. P value for difference between pT2 and pT3 was assessed using the Mann-Whitney U test.